Melanie Mahtani has been named executive advisor of commercial development at Med BioGene.
Mahtani was most recently vice president of corporate business development at Panomics where she led the company's strategic partnering activities with diagnostics, pharmaceutical, and biotechnology companies. Before Panomics, Mahtani served as director of microarray systems R&D at Amersham Biosciences and as vice president of business development and scientific collaboration at Genospectra.
Mahtani holds a PhD in genetics from Stanford University.
Affymetrix has promoted Kevin King to president of the company from his previous post as vice president of life sciences and executive vice president. King joined Affy in January of this year. Prior to that, he was CEO and president of Thomson Healthcare and also held executive-level roles at GE Healthcare and Hewlett-Packard.